Company news

Journey Medical Corporation news

Latest news releases, newest first. Pick a year for every news release, call and deck from that year.

View company

Journey Medical Corporation Announces First Patient Dosed in Phase 3 Clinical Trial Evaluating DFD-29 (Minocycline Modified Release Capsules 40 mg) for the Treatment of Rosacea

March 16, 2022

Journey Medical Corporation to Present at the 34th Annual ROTH Conference

March 8, 2022

QBREXZA® (Rapifort® Wipes 2.5%) Receives Manufacturing and Marketing Approval in Japan Triggering $2.5 Million Milestone Payment to Journey Medical Corporation

February 10, 2022

Journey Medical Corporation Acquires Two FDA-Approved Topical Minocycline Products and Molecule Stabilizing Technology (MST)™ Franchise from VYNE Therapeutics, Inc.

January 12, 2022

Journey Medical Corporation Reports Third Quarter 2021 Financial Results and Recent Corporate Highlights

December 9, 2021

Journey Medical Corporation to Present at the Benzinga Global Small Cap Conference

December 6, 2021

Journey Medical Corporation Introduces Expanded Board of Directors

November 28, 2021

Journey Medical Corporation Announces Closing of Initial Public Offering

November 15, 2021

Dermira Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

December 9, 2019

Dermira Receives Fast Track Designation from FDA for Lebrikizumab for the Treatment of Atopic Dermatitis

December 9, 2019

Dermira Elects Halley E. Gilbert to its Board of Directors

November 12, 2019

Dermira Reports Third Quarter 2019 Financial Results and Provides Corporate Update

November 4, 2019

← Newer news releases

Calls

The 5 newest of 19 calls. Every call is listed under its year.

Decks